Announcements Trials

Browse Landscape

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Recurrence 2 Carcinoma, Hepatocellular 1 Biliary Tract Neoplasms 1

Interventions

Gemcitabine 95 Cisplatin 72 Capecitabine 39 Oxaliplatin 38 durvalumab 29 Fluorouracil 27 pembrolizumab 26 Leucovorin 23 S 1 (combination) 19 Nivolumab 14 Irinotecan 14 lenvatinib 13 Bevacizumab 13 tremelimumab 10 130-nm albumin-bound paclitaxel 9 apatinib 8 Trastuzumab 7 Injections 7 Immune Checkpoint Inhibitors 7 Docetaxel 7 Albumin-Bound Paclitaxel 7 Paclitaxel 6 Drug Therapy 6 titanium silicide 5 surufatinib 5 irinotecan sucrosofate 5 gemcitabine-oxaliplatin regimen 5 envafolimab 5 camrelizumab 5 atezolizumab 5

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Biliary Tract Neoplasms × DNA, Mitochondrial × Clear all

NCT06653127 2024-12-30

CCGLC-016

Tongji Hospital

Gastrointestinal

Biliary Tract Neoplasms, Recurrence

Data powered by HemOnc (CC BY 4.0) Colophon ⚡